Three new contributors have joined us this week; it apparently pays to advertise.

The third, Scott Brouilette, will be writing under the handle An aged post-doc. Appropriately, Scott is a post-doc (of unspecified age) at the William Harvey Research Institute in London. He is working under the guidance of Professor Ken Suzuki, an MD/PhD interested in cellular therapy for the treatment of heart failure.

Scott’s primary interests are related to the role of telomere and telomerase biology in cardiovascular disease. His first post is on a subject near to his heart.